Submitted by Lorenzo.Piemonte on Fri, 12/02/2011 - 17:27
Providing an accurate estimate of the number of children with type 1 diabetes is an essential component of planning health policy, assessing the quality of care and driving research. There is good evidence that the incidence of type 1 diabetes among children is increasing in many parts of the world. The International Diabetes Federation’s Diabetes Atlas, 5th edition, estimates that increase to be 3% per year. The cause of this rise is unknown, although it may be linked to a number of factors.
Submitted by Lorenzo.Piemonte on Tue, 09/13/2011 - 16:59
Among the prison population, psychological disorders and infectious diseases, such as hepatitis and HIV/AIDS, are the most widely recognized medical conditions. According to the authors of this report from France, diabetes is one of the ‘forgotten diseases’ in the penal system. Although in wider society diabetes is recognized as a chronic public health issue, there are very few data on people with diabetes in prison.
Submitted by Lorenzo.Piemonte on Thu, 07/07/2011 - 11:49
Last year, ID F’s Taskforce on Epidemiology and Prevention of Diabetes convened a working group to review the role of surgery in the treatment and prevention of type 2 diabetes. Bariatric surgery, in which the gastrointestinal tract is operated on with the intention of achieving weight loss, has been shown to have significant metabolic benefit. In December last year, 20 people representing all the ID F regions, and different clinical disciplines, met at ID F’s headquarters to review the available evidence and consider the potential of the procedures for people with diabetes.
Submitted by admin on Mon, 07/05/2010 - 15:52
In 1970, parents of children with type 1 diabetes in America organized what has become the Juvenile Diabetes Research Foundation (JDRF). The JDRF’s mission, then as now, has been constant: to find a cure for type 1 diabetes and its complications through the vehicle of research. JDRF has grown to be the world’s largest charitable funder and advocate for type 1 diabetes research. Although based in the USA, JDRF has always supported the best research in type 1 diabetes, wherever it may be.
Submitted by admin on Mon, 07/05/2010 - 15:41
Globally, where the test is available, the measurement of haemoglobin A1c (HbA1c) has become central to the management of diabetes. By giving an objective assessment of glucose control over the preceding 2 to 3 months, it can guide treatment decisions in a way that single blood glucose measurements cannot. The authors describe efforts to standardize and improve the way HbA1c is reported, and explain the practical implications of the recent changes in the way the test is measured.
Submitted by admin on Mon, 07/05/2010 - 15:01
At the end of March 2010, a diabetes prevalence survey attracted the attention of the world’s general media. Diabetes prevalence surveys are not usually terribly exciting to audiences outside the world of epidemiology but the number of people in China estimated to have diabetes now was so large that it took the news world by surprise. The findings of the study have a number of important implications for China and beyond. International Diabetes Federation epidemiologist, David Whiting describes why this study is important and how it adds to our knowledge about the diabetes pandemic.
Submitted by admin on Tue, 12/01/2009 - 14:50
Access to diabetes care in many countries is problematic due to a variety of factors. These can range from the cost of medication to the distance that people with diabetes need to travel to access a trained healthcare provider. Without adequate access to medication and care, people with diabetes face complications and early death. The authors report on an evaluation of the provision of care and supplies for people with diabetes in Vietnam.
Submitted by admin on Fri, 11/27/2009 - 11:18
It may be a surprise to hear that at present there is no overall plan or framework to coordinate or fund research into diabetes across Europe – despite the urgent attention called to the disease from many organizations both patient-led and professional. Although investigators within different research fields and individual research groups have a good idea of where their research is heading, and although national diabetes associations may have drawn up research strategies in order to use national funds wisely, there is no Europe-wide strategy.
Submitted by admin on Mon, 05/04/2009 - 16:38
The diagnosis of gestational diabetes has for decades been based either on criteria that predict a mother’s risk for developing type 2 diabetes in the future, or those used for non-pregnant women. But gestational diabetes also carries a risk for the baby. Moreover, the level at which maternal blood glucose provokes risk for the foetus remains unclear.
Submitted by admin on Tue, 03/17/2009 - 14:13
Recently, two clinical trials addressed the role of tight blood glucose control on cardiovascular risk in people with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study and the Action in Diabetes and Vascular Disease (ADVANCE) trial. The ACCORD study included 10,251 people with type 2 diabetes and was designed to determine whether intensive blood glucose control (HbA1c below 6%) as compared to a conventional approach (HbA1c between 7% and 7.9%) would result in favourable cardiovascular outcomes in people with type 2 diabetes at high vascular risk.